We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




DTI Brain Scan Detects Earliest Signs of Alzheimer's

By HospiMedica International staff writers
Posted on 26 Jan 2010
A new type of brain scan, called diffusion tensor imaging (DTI), appears to be better at detecting whether an individual with memory loss might have brain changes of Alzheimer's disease (AD). More...


The study's findings were published in the January 6, 2010, online issue of the journal Neurology, the medical journal of the American Academy of Neurology. "As better medicines for Alzheimer's disease become available, it will be important to identify people at high risk for the disease as early and accurately as possible so treatment can be most effective,” said Norbert Schuff, Ph.D., with the University of California, San Francisco (UCSF; USA) and the Veterans Affairs Medical Center, San Francisco, author of an editorial about the research.

For the study, 76 healthy people in Rome (Italy) aged 20 to 80 underwent DTI-magnetic resonance imaging (MRI) brain scanning, which is more sensitive than conventional MRI for detecting changes in brain chemistry, thereby mapping fiber tracts that connect brain regions. The researchers examined MRI-DTI changes in the hippocampus, a region of the brain that is critical to memory and one that is involved in AD.

Participants were given verbal tests and tests that measured visual perception of space between objects. Scientists compared the brain scans and found that changes in DTI imaging better clarified declines in memory than did measuring hippocampus volume through a traditional MRI scan. They found that mean diffusivity in the hippocampus better predicted verbal and spatial memory performance in the participants, especially in those who were 50 years of age, or older.

"Our findings show this type of brain scan appears to be a better way to measure how healthy the brain is in people who are experiencing memory loss. This might help doctors when trying to differentiate between normal aging and diseases like Alzheimer's,” said study author Giovanni Carlesimo, Ph.D., from Tor Vergata University (Rome, Italy). "DTI, along with MRI, could serve as an important tool in understanding how and why a person experiences memory decline.”

Related Links:
University of California, San Francisco
Tor Vergata University




Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.